Document:

​

EXHIBIT 10.2
GAIN THERAPEUTICS INC.
2021 INDUCEMENT EQUITY INCENTIVE PLAN
NON-QUALIFIED STOCK OPTION AWARD AGREEMENT
This Non-Qualified Stock Option Award Agreement (this “Option Award Agreement”), dated as of __________, ____ (the “Date of Grant”), is made by and between Gain Therapeutics Inc., a Delaware corporation (the “Company”), and ________ (the “Participant”).  Any capitalized terms used but not defined herein shall have the meaning ascribed to them in the Gain Therapeutics Inc. 2021 Inducement Equity Incentive Plan (as may be amended from time to time, the “Plan”).
1.Grant of Non-Qualified Stock Option.  The Company hereby grants to the Participant an option to purchase ________ Shares at an Exercise Price of $_____ per share (the “Option”), subject to all of the terms and conditions of this Option Award Agreement and the Plan.   The Option is intended to qualify as an inducement grant under Rule 5635(c)(4) of the NASDAQ Listing Rules and the related guidance issued thereunder and is being granted in order to provide an inducement material to the Participant’s entry into employment with the Company.
2.Vesting.
(a)The Shares subject to the Option shall become vested as follows: one-fourth (1/4th) of the Shares subject to the Option shall vest on the first anniversary of the Date of Grant (the “Initial Vesting Date”) and the remaining three-fourths (3/4ths) of the Shares subject to the Option shall vest in a series of thirty-six (36) successive equal monthly installments on each subsequent monthly anniversary of the Initial Vesting Date (each a “Vesting Date”) such that the entirety of the Option shall be vested as of the fourth (4th) anniversary of the Date of Grant; provided that the Participant remains in continuous employment with the Company or an Affiliate thereof through, and has not given or received a notice of termination of such employment as of, each applicable Vesting Date.
(b)Except as set forth in Section 2(c) below, if the Participant’s employment is terminated for any reason prior to the Vesting Date, (i) this Option Award Agreement shall terminate and all rights of the Participant with respect to the Shares subject to the Option that have not vested shall immediately terminate, (ii) any such unvested Shares subject to the Option shall be forfeited without payment of any consideration, and (iii) neither the Participant nor any of the Participant’s successors, heirs, assigns, or personal representatives shall thereafter have any further rights or interests in such unvested Shares subject to the Option.
(c)If the Participant’s employment is terminated either (x) by the Company without Cause or (y) due to the Participant’s death or Disability, and provided in each case that the Participant (or the Participant’s estate, if applicable) executes and delivers to the Company (and does not revoke) a general release of claims in a form satisfactory to the Company within sixty (60) days following such termination (or such shorter period as may be specified by the Company in accordance with applicable law): (i) the portion of the Shares subject to the Option that are scheduled to vest during the period that is six (6) months following such termination date shall immediately vest on the date of such termination of employment, (ii) this Option Award
​

​

​

​
Agreement shall terminate and all rights of the Participant with respect to the portion of the Shares subject to the Option, if any, that have not vested as of the date of termination in accordance with this Section 2(c) shall immediately terminate without payment of any consideration, and (iii) neither the Participant nor any of the Participant’s successors, heirs, assigns, or personal representatives shall thereafter have any further rights or interests in such unvested Shares subject to the Option.
3.Timing of Exercise.  Following the vesting of the Option as set forth in Section 2 hereof, the Participant may exercise all or any portion of such Option, for whole Shares, at any time prior to the earliest to occur of:
(a)The 10th anniversary of the Date of Grant;
(b)The 1st anniversary of the date of the Participant’s termination of due to the Participant’s death or Disability;
(c)Ninety (90) days following the date of the Participant’s termination of employment with the Company or any Affiliate as a result of a voluntary termination by the Participant or by the Company without Cause; and
(d)The close of business on the last business day immediately prior to the date of the Participant’s (A) termination of employment by the Company for Cause or (B) breach of any restrictive covenants set forth in any agreement or other arrangement between the Participant and the Company or any of its Affiliates.
4.Method of Exercise.  The Participant may exercise the Option by giving written notice of exercise to the Company specifying the number of Shares to be purchased, accompanied by payment in full of the aggregate exercise price of the Shares so purchased in cash or its equivalent; provided, that, notwithstanding the foregoing, and unless otherwise determined by the Administrator, the Participant shall be permitted, at his or her election, to satisfy payment of the aggregate exercise price of such Shares by cashless exercise or net share settlement, pursuant to which the Company shall withhold from the number of Shares that would otherwise be issued upon exercise of the Option the largest whole number of Shares with a Fair Market Value equal to the aggregate exercise price of the Shares with respect to which the Option is being exercised.
5.Voting and Other Rights.  The Participant shall have no rights of a stockholder with respect to the Shares subject to the Option (including the right to vote and the right to receive distributions or dividends) unless and until Shares are issued in respect of the exercise of the Option in accordance with Section 4 hereof.
6.Option Award Agreement Subject to Plan.  This Option Award Agreement is made pursuant to all of the provisions of the Plan, which is incorporated herein by this reference, and is intended, and shall be interpreted in a manner, to comply therewith.  In the event of any conflict between the provisions of this Option Award Agreement and the provisions of the Plan, the provisions of the Plan shall govern.  The Participant hereby acknowledges receipt of a copy of the Plan.  The Participant hereby acknowledges that all decisions, determinations and
​
​

​

​

​
interpretations of the Administrator in respect of the Plan, this Option Award Agreement and the Option shall be final and conclusive.
7.No Rights to Employment.  Nothing in the Plan or this Option Award Agreement shall confer upon the Participant any right to employment at the Company or any Affiliate thereof or shall interfere with or restrict the right of the Company or its Affiliates to terminate the Participant’s employment at any time for any reason whatsoever, with or without cause.
8.Tax Withholding.  The Company shall be entitled to require a cash payment by or on behalf of the Participant in respect of any sums required or permitted by federal, state or local tax law to be withheld with respect in respect of the Option; provided, that, notwithstanding the foregoing, and unless otherwise determined by the Administrator, the Participant shall be permitted, at his or her election, to satisfy the applicable tax obligations with respect to the Option by cashless exercise or net share settlement, pursuant to which the Company shall withhold from the number of Shares that would otherwise be issued upon exercise of the Option the largest whole number of Shares with a Fair Market Value equal to the applicable tax obligations.
9.Governing Law.  This Option Award Agreement shall be governed by and construed in accordance with the laws of the State of Delaware, without giving effect to the principles of conflicts of law of such state.
10.Option Award Agreement Binding on Successors.  The terms of this Option Award Agreement shall be binding upon the Participant and upon the Participant’s heirs, executors, administrators, personal representatives, transferees, assignees and successors in interest, and upon the Company and its successors and assignees, subject to the terms of the Plan.
11.No Assignment.  Notwithstanding anything to the contrary in this Option Award Agreement, neither this Option Award Agreement nor any rights granted herein shall be assignable by the Participant.
12.Nature of Grant.  This Option Award Agreement is intended to comply with the applicable laws of any country or jurisdiction where Options are granted under the Plan, and all provisions hereof shall be construed in a manner to so comply.  In accepting this Option, the Participant acknowledges, understands and agrees that:
(a)the Plan is established voluntarily by the Company, it is discretionary in nature, and may be amended, suspended or terminated by the Company at any time, to the extent permitted by the Plan;
(b)the grant of this Option is voluntary and occasional and does not create any contractual or other right to receive future grants of options, or benefits in lieu of options, even if options have been granted in the past;
(c)all decisions with respect to future options or other grants, if any, will be at the sole discretion of the Company;
​
​

​

​

​
(d)the Participant is voluntarily participating in the Plan;
(e)this Option and any Shares acquired under the Plan are not intended to replace any pension rights or compensation;
(f)this Option and any Shares acquired under the Plan and the income and value of same, are not part of the Participant’s normal or expected compensation for any purpose, including, without limitation, calculating any severance, resignation, termination, redundancy, dismissal, end-of-service payments, bonuses, long-service awards, pension or retirement or welfare benefits or similar payments;
(g)the future value of the Shares underlying this Option is unknown, indeterminable, and cannot be predicted with certainty;
(h)if the underlying Shares do not increase in value, this Option will have no value;
(i)if the Participant exercises this Option and acquires Shares, the value of such Shares may increase or decrease in value, even below the exercise price;
(j)to the extent permitted by applicable law, no claim or entitlement to compensation or damages shall arise from the forfeiture of this Option resulting from the termination of the Participant’s employment or service with the Company or an Affiliate (for any reason whatsoever, whether or not later found to be invalid or in breach of employment laws in the jurisdiction where the Participant is providing continuous employment or the terms of the Participant’s employment agreement, if any), and in consideration of the grant of this Option to which the Participant is otherwise not entitled, the Participant irrevocably agrees never to institute any claim against the Company or an Affiliate, waive the Participant’s ability, if any, to bring any such claim, and release the Company or an Affiliate from any such claim; if, notwithstanding the foregoing, any such claim is allowed by a court of competent jurisdiction, then, by participating in the Plan, the Participant shall be deemed irrevocably to have agreed not to pursue such claim and agree to execute any and all documents necessary to request dismissal or withdrawal of such claim;
(k)for purposes of this Option, the Participant’s employment or service will be considered terminated as of the date the Participant is no longer actively providing services to the Company or an Affiliate (regardless of the reason for such termination and whether or not later found to be invalid or in breach of employment laws in the jurisdiction where the Participant is providing employment or service or the terms of the Participant’s employment agreement, if any), and unless otherwise expressly provided in this Option Award Agreement or determined by the Company, (i) the Participant’s right to vest in this Option will terminate as of such date and will not be extended by any notice period (e.g., the Participant’s period of employment or service would not include any contractual notice period or any period of “garden leave” or similar period mandated under employment laws in the jurisdiction where the Participant is providing employment or service or the terms of the Participant’s employment agreement, if any); and (ii) the period (if any) during which the Participant may exercise this Option after such termination of employment or service will commence on the date the Participant cease to actively provide services and will not be extended by any notice period mandated under employment laws in the jurisdiction
​
​

​

​

​
where the Participant is providing employment or service or the terms of the Participant’s employment agreement, if any; the Company shall have the exclusive discretion to determine when the Participant is no longer actively providing services for purposes of this Option (including whether the Participant may still be considered to be providing services while on a leave of absence);
(l)unless otherwise provided in the Plan or by the Company in its discretion, this Option and the benefits evidenced by this Option Award Agreement do not create any entitlement to have this Option or any such benefits transferred to, or assumed by, another company nor to be exchanged, cashed out or substituted for, in connection with any corporate transaction affecting the Shares; and
(m)the Participant acknowledges and agrees that neither the Company nor an Affiliate shall be liable for any foreign exchange rate fluctuation between the Participant’s local currency and the United States Dollar that may affect the value of this Option or of any amounts due to the Participant pursuant to the exercise of the option or the subsequent sale of any Shares acquired upon exercise.
13.DATA PRIVACY. The Participant hereby explicitly and unambiguously consents to the collection, use and transfer, in electronic or other form, of the Participant’s personal data as described in this Option Award Agreement and any other option grant materials by and among, as applicable, the Company and any Affiliate for the exclusive purpose of implementing, administering and managing participation in the Plan. The Participant understands that the Company and any Affiliate may hold certain personal information about the Participant, including, but not limited to, the Participant’s name, home address and telephone number, date of birth, social insurance number or other identification number, salary, nationality, job title, any shares of stock or directorships held in the Company, details of all options or any other entitlement to Shares awarded, canceled, exercised, vested, unvested or outstanding in the Participant’s favor (“Data”), for the exclusive purpose of implementing, administering and managing the Plan.  The Participant understands that Data will be transferred to a third party stock plan service provider as may be selected by the Company in the future, which is assisting the Company with the implementation, administration and management of the Plan. The Participant understands that the recipients of the Data may be located in the United States or elsewhere, and that the recipient’s country (e.g., the United States) may have different data privacy laws with a lower level of protection than the Participant’s country. The Participant understands that he or she may request a list with the names and addresses of any potential recipients of the Data by contacting his or her local human resources representative. The Participant authorizes the Company, and any other  possible recipients which may assist the Company (presently or in the future) with implementing, administering and managing the Plan to receive, possess, use, retain and transfer the Data, in electronic or other form, for the sole purposes of implementing, administering and managing the Participant’s participation in the Plan. The Participant understands that Data will be held only as long as is necessary to implement, administer and manage the Participant’s participation in the Plan.  The Participant understands that he or she may, at any time, view Data, request additional information about the storage and processing of Data, require any necessary amendments to Data or refuse or withdraw the consents herein, in any case without cost, by
​
​

​

​

​
contacting in writing his or her local human resources representative. Further, the Participant understands that he or she is providing the consents herein on a purely voluntary basis. If the Participant does not consent, or if the Participant later seeks to revoke his or her consent, the Participant’s continuous employment and career with the Company or an Affiliate will not be adversely affected; the only adverse consequence of refusing or withdrawing consent is that the Company would not be able to grant the Participant options or other equity awards or administer or maintain such awards. Therefore, the Participant understands that refusing or withdrawing consent may affect his or her ability to participate in the Plan. For more information on the consequences of the Participant’s refusal to consent or withdrawal of consent, the Participant understands that he or she may contact his or her local human resources representative.
14.Necessary Acts.  The Participant hereby agrees to perform all acts, and to execute and deliver any documents that may be reasonably necessary to carry out the provisions of this Option Award Agreement, including but not limited to all acts and documents related to compliance with federal and/or state securities and/or tax laws.
15.Severability.  Should any provision of this Option Award Agreement be held by a court of competent jurisdiction to be unenforceable, or enforceable only if modified, such holding shall not affect the validity of the remainder of this Option Award Agreement, the balance of which shall continue to be binding upon the parties hereto with any such modification (if any) to become a part hereof and treated as though contained in this original Option Award Agreement.  Moreover, if one or more of the provisions contained in this Option Award Agreement shall for any reason be held to be excessively broad as to scope, activity, subject or otherwise so as to be unenforceable, in lieu of severing such unenforceable provision, such provision or provisions shall be construed by the appropriate judicial body by limiting or reducing it or them, so as to be enforceable to the maximum extent compatible with the applicable law as it shall then appear, and such determination by such judicial body shall not affect the enforceability of such provisions or provisions in any other jurisdiction.
16.Entire Agreement.  This Option Award Agreement and the Plan contain the entire agreement and understanding among the parties as to the subject matter hereof, and supersede any other agreements or representations, oral or otherwise, express or implied, with respect to the subject matter hereof.
17.Headings.  Headings are used solely for the convenience of the parties and shall not be deemed to be a limitation upon or descriptive of the contents of any such Section.
18.Counterparts; Electronic Signature.  This Option Award Agreement may be executed in any number of counterparts, each of which shall be deemed to be an original and all of which together shall be deemed to be one and the same instrument.  The Participant’s electronic signature of this Option Award Agreement shall have the same validity and effect as a signature affixed by the Participant’s hand.
19.Amendment.  No amendment or modification hereof shall be valid unless it shall be in writing and signed by all parties hereto.
​
​

​

​

​
20.Set-Off.  The Participant hereby acknowledges and agrees, without limiting the rights of the Company or any Affiliate thereof otherwise available at law or in equity, that, to the extent permitted by law, any amount due to the Participant under this Option Award Agreement may be reduced by, and set-off against, any or all amounts or other consideration payable by the Participant to the Company or any of its Affiliates under any other agreement or arrangement between the Participant and the Company or any of its Affiliates; provided that any such set-off does not result in a penalty under Section 409A of the Code.
[Signature Pages Follow]
​
​

​

​

IN WITNESS WHEREOF, the parties hereto have executed this Option Award Agreement as of the date set forth above.
​
	​

	​

	​

	GAIN THERAPEUTICS INC.
	​

	​
	​

	​
	​

	By:
	​
	​

	​
	​
	​

	Print Name:
	​
	​

	​
	​
	​

	Title:
	​
	​

	​
	​
	​

​
​

[Signature Page to Non-Qualified Stock Option Award Agreement]

​

​
The undersigned hereby accepts and agrees to all the terms and provisions of the foregoing Option Award Agreement.
​
	​

	​

	​

	PARTICIPANT
	​

	​
	​

	​
	​

	Signature:
	​
	​

	​
	​
	​

	Print Name:
	​
	​

	​
	​
	​

	Address:
	​
	​

	​
	​
	​

	​
	​
	​

​

[Signature Page to Non-Qualified Stock Option Award Agreement]Exhibit 10.1

 

FORM OF SUBSCRIPTION AGREEMENT

 

 

CC Neuberger Principal Holdings II 

200 Park Avenue, 58th Floor 

New York, New York 10166

 

Ladies and Gentlemen:

 

This
Subscription Agreement (this “Subscription Agreement”) is being entered into as of the date set forth on the signature
page hereto, by and between CC Neuberger Principal Holdings II, a Cayman Islands exempted company (“SPAC”),
Vector Holding, LLC, a Delaware limited liability company and wholly-owned subsidiary of the SPAC (“New CCNB”), and
the undersigned investor (the “Investor”), in connection with the Business Combination Agreement, dated as of December 9,
2021 (as may be amended, supplemented or otherwise modified from time to time, the “Business Combination Agreement”),
by and among the SPAC, New CCNB, Griffey Global Holdings, Inc., a Delaware corporation (the “Company”), Vector
Domestication Merger Sub, LLC, a Delaware limited liability company and wholly-owned subsidiary of New CCNB (“Domestication
Merger Sub”), Vector Merger Sub 1, LLC, a Delaware limited liability company and wholly-owned subsidiary of the SPAC (“Vector
Merger Sub 1”), Vector Merger Sub 2, LLC, a Delaware limited liability company and wholly-owned subsidiary of the SPAC (“Vector
Merger Sub 2) and for limited purposes as set forth in the Business Combination Agreement, Griffey Investors, LP, a Delaware limited
partnership, pursuant to which, among other things, (i) New CCNB will convert into a Delaware corporation (the “Statutory
Conversion”), (ii) following the Statutory Conversion, the SPAC will merge with and into Domestication Merger Sub (the
 “Domestication Merger”), with Domestication Merger Sub surviving the Domestication Merger (the “Domestication
Surviving Company”), (iii) following the Domestication Merger, G Merger Sub I will merge with and into the Company (the
 “First Getty Merger”), with the Company surviving the First Getty Merger (the “First Surviving Company”)
and (iv) immediately following the First Getty Merger, the First Surviving Company will merge with and into G Merger Sub 2 (the
 “Second Getty Merger,” and together with the First Getty Merger, the “Getty Mergers”, and together
with the Domestication Merger, the “Mergers”), with G Merger Sub 2 surviving the Second Getty Merger as a wholly owned
subsidiary of the First Surviving Company (the “Final Surviving Company”), on the terms and subject to the conditions
therein (the transactions contemplated by the Business Combination Agreement, including the Mergers, the “Transaction”).
In connection with the Transaction, SPAC is seeking commitments from interested investors to purchase, following the Domestication Merger
and prior to the Getty Mergers, shares of New CCNB’s Class A common stock, par value $0.0001 per share (the “Shares”),
in a private placement for a purchase price of $10.00 per share (the “Per Share Purchase Price”). On December 9,
2021, SPAC and New CCNB entered into subscription agreements (the “Other Subscription Agreements”) with certain other
investors (the “Other Investors”), pursuant to which the Other Investors have agreed to purchase on the closing date
of the Transaction an aggregate amount of up to 15,000,000 Shares, at the Per Share Purchase Price (the “Other PIPE Investment
Shares”). As of the date hereof, the Investor has agreed to purchase on the closing date of the Transaction an aggregate amount
of Shares (as set forth on the signature page hereto), at the Per Share Purchase Price, and such issuance of Shares shall be in
addition to the Other PIPE Investment Shares. The aggregate purchase price to be paid by the Investor for the subscribed Shares (as set
forth on the signature page hereto) is referred to herein as the “Subscription Amount.”

 

References to the “Issuer”
shall refer to the SPAC for all periods prior to completion of the Domestication Merger and to New CCNB for all periods after completion
of the Domestication Merger.

 

In connection therewith,
and in consideration of the foregoing and the mutual representations, warranties and covenants, and subject to the conditions, set forth
herein, and intending to be legally bound hereby, each of the Investor and Issuer acknowledges and agrees as follows:

 

1.            Subscription.
The Investor hereby irrevocably subscribes for and agrees to purchase from Issuer the number of Shares set forth on the signature page of
this Subscription Agreement on the terms and subject to the conditions provided for herein. The Investor acknowledges and agrees that
Issuer reserves the right to accept or reject the Investor’s subscription for the Shares for any reason or for no reason, in whole
or in part, at any time prior to its, his or her acceptance, and the same shall be deemed to be accepted by Issuer only when this Subscription
Agreement is signed by a duly authorized person by or on behalf of Issuer; Issuer may do so in counterpart form. The Investor acknowledges
and agrees that, as a result of the Transaction, the Shares that will be purchased by the Investor and issued by Issuer pursuant to this
Subscription Agreement shall be shares of common stock in a Delaware corporation (and not, for the avoidance of doubt, ordinary shares
in a Cayman Islands exempted company).

 

     

     

    

 

2.            Closing.
The closing of the sale of the Shares contemplated hereby (the “Closing”) is contingent upon the substantially concurrent
consummation of the Transaction. The Closing shall occur substantially concurrently with and be conditioned upon the effectiveness of,
the Transaction. Upon delivery of written notice from (or on behalf of) Issuer to the Investor (the “Closing Notice”),
that Issuer reasonably expects all conditions to the closing of the Transaction to be satisfied or waived on a date that is not less
than five (5) business days from the date on which the Closing Notice is delivered to the Investor, the Investor shall deliver to
Issuer, three (3) business days prior to the closing date specified in the Closing Notice (the “Closing Date”),
(i) the Subscription Amount by wire transfer of United States dollars in immediately available funds to the account(s) specified
by Issuer in the Closing Notice and (ii) any other information that is reasonably requested in the Closing Notice in order for the
Shares to be issued to the Investor, including, without limitation, the legal name of the person in whose name such Shares are to be
issued and a duly executed Internal Revenue Service Form W-9 or W-8, as applicable. At the Closing, a number of Shares shall be
issued to the Investor set forth on the signature page to this Subscription Agreement and subsequently such Shares shall be registered
in book entry form in the name of the Investor on Issuer’s share register; provided, however, that the obligation
to issue the Shares to the Investor is contingent upon Issuer having received the Subscription Amount in full accordance with this Section 2.
If the Closing does not occur within ten (10) business days following the Closing Date specified in the Closing Notice, Issuer
shall promptly (but not later than three (3) business days thereafter) return the Subscription Amount in full to the Investor; provided
that, unless this Subscription Agreement has been terminated pursuant to Section 8 hereof, such return of funds shall not
terminate this Subscription Agreement or relieve the Investor of its, his or her obligation to purchase the Shares at the Closing upon
the delivery by Issuer of a subsequent Closing Notice in accordance with this Section 2. For purposes of this Subscription
Agreement, “business day” shall mean a day other than a Saturday, Sunday or other day on which commercial banks in New York,
New York are authorized or required by law to close.

 

3.            Closing
Conditions.

 

a.            The
obligation of the parties hereto to consummate the purchase and sale of the Shares pursuant to this Subscription Agreement is subject
to the following conditions:

 

(i)            no
applicable governmental authority shall have enacted, issued, promulgated, enforced or entered any judgment, order, law, rule or
regulation (whether temporary, preliminary or permanent) which is then in effect and has the effect of making the consummation of the
transactions contemplated hereby illegal or otherwise restraining or prohibiting consummation of the transactions contemplated hereby;
and

 

(ii)            (A) all
conditions precedent to the closing of the Transaction contained in the Business Combination Agreement shall have been satisfied (as
determined by the parties to the Business Combination Agreement and other than those conditions under the Business Combination Agreement
which, by their nature, are to be fulfilled at the closing of the Transaction, including to the extent that any such condition is dependent
upon the consummation of the purchase and sale of the Shares pursuant to this Subscription Agreement) or waived according to the terms
of the Business Combination Agreement and (B) the closing of the Transaction shall be scheduled to occur concurrently with or on
the same date as the Closing.

 

b.            The
obligation of Issuer to consummate the issuance and sale of the Shares pursuant to this Subscription Agreement shall be subject to the
conditions that (i) all representations and warranties of the Investor contained in this Subscription Agreement are true and correct
in all material respects at and as of the Closing (except for those representations and warranties qualified by materiality, which shall
be true and correct in all respects and those representations and warranties that speak as of a specified earlier date, which shall be
so true and correct in all material respects (or, if qualified by materiality, in all respects) as of such earlier date), and consummation
of the Closing shall constitute a reaffirmation by the Investor of each of the representations and warranties of the Investor contained
in this Subscription Agreement as of the Closing; and (ii) all obligations, covenants and agreements of the Investor required to
be performed by it, him or her at or prior to the Closing shall have been performed in all material respects.

 

     

     

    

 

c.            The
obligation of the Investor to consummate the purchase of the Shares pursuant to this Subscription Agreement shall be subject to the conditions
(which may be waived by the Investor) that (i) all representations and warranties of Issuer contained in this Subscription Agreement
shall be true and correct in all material respects at and as of the Closing (other than representations and warranties that are qualified
as to materiality or Material Adverse Effect (as defined herein), which representations and warranties shall be true in all respects
and those representations and warranties that speak as of a specified earlier date, which shall be so true and correct in all material
respects (or, if qualified by materiality, in all respects) as of such earlier date), and consummation of the Closing shall constitute
a reaffirmation by Issuer of each of the representations and warranties of Issuer contained in this Subscription Agreement as of the
Closing; (ii) all obligations, covenants and agreements of Issuer required by this Subscription Agreement to be performed by it
at or prior to the Closing shall have been performed in all material respects; (iii) there shall have been no amendment or modification
to the Business Combination Agreement that would reasonably be expected to materially and adversely affect the economic benefits that
Investor would reasonably expect to receive under this Subscription Agreement, except to the extent consented to in writing by Investor;
provided that the foregoing condition shall not apply with respect to any amendment, modification or waiver of Section 9.3(c) of
the Business Combination Agreement (or the effects thereof); and (iv) New CCNB’s initial listing application with The New
York Stock Exchange (“NYSE”) in connection with the Transaction shall have been conditionally approved and, immediately following
the closing of the Transaction, New CCNB would satisfy any applicable listing requirements of NYSE as at the Closing Date, and the Shares
shall have been approved for listing on NYSE, subject to official notice of issuance.

 

4.            Further
Assurances. At or prior to the Closing, the parties hereto shall execute and deliver, or cause to be executed and delivered, such
additional documents and take such additional actions as the parties reasonably may deem to be practical and necessary in order to consummate
the subscription as contemplated by this Subscription Agreement.

 

5.            Issuer
Representations and Warranties. Issuer represents and warrants to the Investor that (provided that no representation or warranty
by Issuer shall apply to any statement or information in the SEC Reports (as defined below) that relates to the topics referenced in
the Statement (as defined below), any reclassification of the Issuer’s public shares or any other accounting matters with respect
to Issuer’s securities or expenses or other initial public offering related matters, nor shall any correction, amendment or restatement
of Issuer’s filings or financial statements arising from or relating to the Statement or any other accounting matters, nor any
other effects that relate to or arise out of, or are in connection with or in response to, any of the foregoing or any changes in accounting
or disclosure related thereto, be deemed to be material for purposes of this Subscription Agreement or be deemed to be a breach of any
representation or warranty by Issuer or a Material Adverse Effect):

 

a.            As
of the date hereof, Issuer is an exempted company duly formed, validly existing and in good standing under the laws of the Cayman
Islands (to the extent such concept exists in such jurisdiction). Issuer has all power (corporate or otherwise) and authority to own,
lease and operate its properties and conduct its business as presently conducted and to enter into, deliver and perform its obligations
under this Subscription Agreement. As of the Closing, following the Domestication Merger, Issuer will be duly formed, validly existing
as a corporation and in good standing under the laws of the State of Delaware.

 

b.            As
of the Closing, the Shares will be duly authorized and, when issued and delivered to the Investor against full payment therefor in accordance
with the terms of this Subscription Agreement, the Shares will be validly issued, fully paid and non-assessable and will not have been
issued in violation of or subject to any preemptive or similar rights created under Issuer’s certificate of incorporation (as adopted
in connection with the Domestication Merger) or under the General Corporation Law of the State of Delaware.

 

c.            This
Subscription Agreement has been duly authorized, executed and delivered by Issuer and, assuming that this Subscription Agreement constitutes
the valid and binding agreement of the Investor, this Subscription Agreement is enforceable against Issuer in accordance with its terms,
except as may be limited or otherwise affected by (i) bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium
or other laws relating to or affecting the rights of creditors generally, or (ii) principles of equity, whether considered at law
or equity.

 

     

     

    

 

d.            The
issuance and sale of the Shares and the compliance by Issuer with all of the provisions of this Subscription Agreement and the consummation
of the transactions contemplated herein will not conflict with or result in a breach or violation of any of the terms or provisions of,
or constitute a default under, or result in the creation or imposition of any lien, charge or encumbrance upon any of the property or
assets of Issuer or any of its subsidiaries pursuant to the terms of (i) any indenture, mortgage, deed of trust, loan agreement,
lease, license or other agreement or instrument to which Issuer or any of its subsidiaries is a party or by which Issuer or any of its
subsidiaries is bound or to which any of the property or assets of Issuer is subject that would reasonably be expected to materially
affect the validity of the Shares or the legal authority of Issuer to timely comply in all material respects with the terms of this Subscription
Agreement (a “Material Adverse Effect”); (ii) result in any violation of the provisions of the organizational
documents of Issuer; or (iii) result in any violation of any statute or any judgment, order, rule or regulation of any court
or governmental agency or body, domestic or foreign, having jurisdiction over Issuer or any of its properties that would reasonably be
expected to have a Material Adverse Effect.

 

e.            As
of their respective dates, all reports (the “SEC Reports”) required to be filed by Issuer with the U.S. Securities
and Exchange Commission (the “SEC”) complied in all material respects with the applicable requirements of the Securities
Act of 1933, as amended (the “Securities Act”) and the Securities Exchange Act of 1934, as amended (the “Exchange
Act”), and the rules and regulations of the SEC promulgated thereunder, and none of the SEC Reports, when filed or, if
amended, as of the date of such amendment, contained any untrue statement of a material fact or omitted to state a material fact required
to be stated therein or necessary in order to make the statements therein, in the light of the circumstances under which they were made,
not misleading. Each Investor acknowledges that (i) the Staff of the SEC issued the Staff Statement on Accounting and Reporting
Considerations for Warrants Issued by Special Purpose Acquisition Companies on April 12, 2021 (together with any subsequent guidance,
statements or interpretations issued by the SEC or the Staff relating thereto or to other accounting matters related to Issuer’s
securities or expenses or other initial public offering related matters, the “Statement”), (ii) Issuer continues
to review the Statement and its implications, including on the financial statements and other information included in the SEC Reports
and (iii) any restatement, revision or other modification of the SEC Reports, including, without limitation, any changes to historical
accounting policies of Issuer and any reclassification of the Issuer’s public shares in connection with any order, directive, guideline,
comment or recommendation from the SEC that is applicable to Issuer, including, without limitation, arising from or relating to Issuer’s
review of the Statement shall be deemed not material for purposes of this Subscription Agreement.

 

f.            Assuming
the accuracy of the Investor’s representations and warranties set forth in Section 6 of this Subscription Agreement,
no registration under the Securities Act is required for the offer and sale of the Shares by Issuer to the Investor hereunder. The Shares
(i) were not offered by any form of general solicitation or general advertising and (ii) are not being offered in a manner
involving a public offering under, or in a distribution in violation of, the Securities Act, or any state securities laws.

 

g.            Other
than (i) the Other Subscription Agreements, (ii) the Business Combination Agreement and any agreement explicitly contemplated
thereby, (iii) any other subscription agreement entered into after the date of this Subscription Agreement with respect to the same
class of shares being acquired by Investor hereunder and at the same Per Share Purchase Price and otherwise on substantially similar
economic terms and in substantially similar form as this Subscription Agreement (each, a “Subsequent Subscription Agreement”
and the investor thereunder, a “Subsequent Investor”), and (iv) any commercial agreement entered into after the date
of this Subscription Agreement that is unrelated to the financing of the Company or New CCNB or fundraising in connection with the Transaction,
the Issuer has not entered into any side letter or similar agreement with any investor in connection with such investor’s direct
or indirect investment in the Issuer (other than any side letter or similar agreement relating to the transfer to any investor of (i) securities
of the Issuer by existing securityholders of the Issuer, which may be effectuated as a forfeiture to the Issuer and reissuance, or (ii) securities
to be issued to the direct or indirect securityholders of the Company pursuant to the Business Combination Agreement). No Subsequent
Subscription Agreement and no Other Subscription Agreement (other than any subscription agreement entered into by CC Neuberger Principal
Holdings II Sponsor LLC or Getty Investment L.L.C., or their affiliates which, however, shall be with respect to the same class of shares
being acquired by Investor hereunder and at the same Per Share Purchase Price) includes terms and conditions that are materially more
advantageous to any such Subsequent Investor or Other Investor than Investor hereunder, and no such Subsequent Subscription Agreement
or Other Subscription Agreement has been amended in any material respect following the date of this Subscription Agreement.

 

     

     

    

 

h.            The
Issuer has prior to the date, or shall on the first (1st) business day immediately following the date hereof, issued or issue
one or more press releases or filed with the SEC a Current Report on Form 8-K that disclosed or discloses all material terms of
the transactions contemplated hereby, by the Other Subscription Agreements and the Business Combination Agreement and other material
nonpublic information that Issuer has provided to the Investor at any time prior to the date hereof.

 

6.            Investor
Representations and Warranties. The Investor represents and warrants to Issuer that:

 

a.            The
Investor (i) is an “accredited investor” (within the meaning of Rule 501(a) under the Securities Act), satisfying
the applicable requirements set forth on Schedule A hereto, (ii) is acquiring the Shares only for its, his or her own account
and not for the account of others and (iii) is not acquiring the Shares with a view to, or for offer or sale in connection with,
any distribution thereof in violation of the Securities Act or any securities laws of the United States or any other jurisdiction. The
Investor has completed Schedule A following the signature page hereto and the information contained therein is accurate and
complete. The Investor further acknowledges that it, he or she is aware that the sale to it, him or her is being made in reliance on
a private placement exempt from registration under the Securities Act and is acquiring the Shares for its, his or her own account.

 

b.            [Reserved.]

 

c.            The
Investor acknowledges and agrees that the Shares are being offered in a transaction not involving any public offering within the meaning
of the Securities Act and that the offer and sale of the Shares have not been registered under the Securities Act or any other applicable
securities laws. The Investor acknowledges and agrees that the Shares may not be offered, resold, transferred, pledged or otherwise disposed
of by the Investor absent an effective registration statement under the Securities Act except in compliance with any exemption therefrom,
and that any book entries representing the Shares shall contain a restrictive legend to such effect, which legend shall be subject to
removal as set forth herein, subject to applicable law. The Investor acknowledges and agrees that the Shares will be subject to transfer
restrictions and, as a result of these transfer restrictions, the Investor may not be able to readily offer, resell, transfer, pledge
or otherwise dispose of the Shares and may be required to bear the financial risk of an investment in the Shares for an indefinite period
of time. The Investor acknowledges and agrees that the Shares will not be eligible for offer, resale, transfer, pledge or disposition
pursuant to Rule 144 promulgated under the Securities Act until at least one year from the date that Issuer files a Current Report
on Form 8-K following the Closing that includes the “Form 10” information required under applicable SEC rules and
regulations. The Investor acknowledges and agrees that it, he or she has been advised to consult legal counsel and tax and accounting
advisors prior to making any offer, resale, transfer, pledge or disposition of any of the Shares.

 

d.            The
Investor acknowledges and agrees that the Investor is purchasing the Shares directly from Issuer. The Investor further acknowledges that
there have been no representations, warranties, covenants and agreements made to the Investor by or on behalf of Issuer, the Company,
and Credit Suisse Securities (USA) LLC, Goldman Sachs & Co. LLC, J.P. Morgan Securities LLC and Citigroup Global Markets Inc.
(collectively, the “Placement Agents”), any of their respective affiliates or any control persons, officers, directors,
employees, partners, agents or representatives of any of the foregoing or any other person or entity, expressly or by implication, other
than those representations, warranties, covenants and agreements of Issuer expressly set forth in Section 6 of this Subscription
Agreement.

 

e.            The
Investor’s acquisition and holding of the Shares will not constitute or result in a non-exempt prohibited transaction under Section 406
of the Employee Retirement Income Security Act of 1974, as amended, Section 4975 of the Internal Revenue Code of 1986, as amended,
or any applicable similar law.

 

     

     

    

 

f.            The
Investor acknowledges and agrees that the Investor has received such information as the Investor deems necessary in order to make an
investment decision with respect to the Shares, including, with respect to Issuer, the Transaction and the business of the Company and
its direct and indirect subsidiaries. Without limiting the generality of the foregoing, the Investor acknowledges that it, he or she
has reviewed the SEC Reports and other information as the Investor has deemed necessary to make an investment decision with respect to
the Shares. The Investor acknowledges and agrees that the Investor and the Investor’s professional advisor(s), if any, have had
the full opportunity to ask such questions, including from the Company directly, receive such answers and obtain such information as
the Investor and such Investor’s professional advisor(s), if any, have deemed necessary to make an investment decision with respect
to the Shares, including but not limited to access to marketing materials and a virtual data room containing information about the Company
and its financial condition, results of operations, business, properties, management and prospects sufficient, in the Investor’s
judgment, to enable the Investor to evaluate its, his or her investment. The Investor acknowledges that certain information provided
by the Company was based on projections, and such projections were prepared based on assumptions and estimates that are inherently uncertain
and are subject to a wide variety of significant business, economic and competitive risks and uncertainties that could cause actual results
to differ materially from those contained in the projections. The Investor further acknowledges that it, he or she has reviewed or had
the full opportunity to review all disclosure documents provided to such Investor in the offering of the Shares and no statement or printed
material which is contrary to such disclosure documents has been made or given to the Investor by or on behalf of Issuer or Company.
Based on such information as the Investor has deemed appropriate and without reliance upon the Placement Agents, the Investor has independently
made its, his or her own analysis and decision to enter into the Transaction. Except for the representations, warranties and agreements
of the Issuer expressly set forth in any Subscription Agreement, the Investor is relying exclusively on its, his or her own sources of
information, investment analysis and due diligence (including professional advice it, he or she deemed appropriate) with respect to the
Transaction, the Securities and the business, condition (financial and otherwise), management, operations, properties and prospects of
the Issuer and the Company, including but not limited to all business, legal, regulatory, accounting, credit and tax matters.

 

g.            The
Investor became aware of this offering of the Shares solely by means of direct contact between the Investor and Issuer, the Company or
a representative of Issuer or the Company, and the Shares were offered to the Investor solely by direct contact between the Investor
and Issuer, the Company or a representative of Issuer or the Company. The Investor did not become aware of this offering of the Shares,
nor were the Shares offered to the Investor, by any other means and none of Issuer, Company or their respective representatives or any
person acting on behalf of any of them acted as investment advisor, broker or dealer to the Investor. The Investor acknowledges that
the Shares (i) were not offered by any form of general solicitation or general advertising and (ii) are not being offered in
a manner involving a public offering under, or in a distribution in violation of, the Securities Act, or any state securities laws. The
Investor acknowledges that it, he or she is not relying upon, and has not relied upon, any statement, representation or warranty made
by any person, firm or corporation (including, without limitation, Issuer, the Company, any of their respective affiliates or any
control persons, officers, directors, employees, partners, agents or representatives of any of the foregoing), other than the representations
and warranties of Issuer contained in Section 5 of this Subscription Agreement, in making its, his or her investment or decision
to invest in Issuer.

 

h.            The
Investor acknowledges that it, he or she is aware that there are substantial risks incident to the purchase and ownership of the Shares,
including but not limited to those set forth in the SEC Reports. The Investor has such knowledge and experience in financial and business
matters as to be capable of evaluating the merits and risks of an investment in the Shares, and the Investor has sought such accounting,
legal and tax advice as the Investor has considered necessary to make an informed investment decision and the Investor has made its,
his or her own assessment and has satisfied itself, himself or herself concerning relevant tax and other economic considerations relative
to its, his or her purchase of the Shares. The Investor will not look to the Placement Agents for all or part of any such loss or losses
the Investor may suffer, is able to sustain a complete loss on its, his or her investment in the Shares, has no need for liquidity with
respect to its, his or her investment in the Shares and has no reason to anticipate any change in circumstances, financial or otherwise,
which may cause or require any sale or distribution of all or any part of the Shares.

 

i.            Alone,
or together with any professional advisor(s), the Investor has adequately analyzed and fully considered the risks of an investment in
the Shares and determined that the Shares are a suitable investment for the Investor and that the Investor is able at this time and in
the foreseeable future to bear the economic risk of a total loss of the Investor’s investment in Issuer. The Investor has determined
based on its, his or her own independent review and such professional advice as the Investor deemed appropriate that its, his or her
purchase of the Securities and participation in the Transaction are fully consistent with its, his or her financial needs, objectives
and condition and is a suitable investment for the Investor, notwithstanding the risks inherent in investing in or holding the Securities.
The Investor acknowledges specifically that a possibility of total loss exists.

 

     

     

    

 

j.            The
Investor hereby acknowledges and agrees that (a) the Placement Agents are acting solely as placement agents in connection with the
Transaction and are not acting as underwriters or in any other capacity and are not and shall not be construed as a fiduciary for the
Investor, the Company or any other person or entity in connection with the Transaction, (b) the Placement Agents have not made and
will not make any representation or warranty, whether express or implied, of any kind or character and have not provided any advice or
recommendation in connection with the Transaction, (c) the Placement Agents will have no responsibility with respect to (i) any
representations, warranties or agreements made by any person or entity under or in connection with the Transaction or any of the documents
furnished pursuant thereto or in connection therewith, or the execution, legality, validity or enforceability (with respect to any person)
or any thereof, or (ii) the business, condition (financial or otherwise), operations, properties or prospects of, or any other matter
concerning the Company, the Target or the Transaction, and (d) the Placement Agents shall have no liability or obligation (including
without limitation, for or with respect to any losses, claims, damages, obligations, penalties, judgments, awards, liabilities, costs,
expenses or disbursements incurred by the Investor, the Company or any other person or entity), whether in contract, tort or otherwise,
to the Investor, or to any person claiming through the Investor, in respect of the Transaction. In making its, his or her decision to
purchase the Shares, the Investor has relied solely upon independent investigation made by the Investor. Without limiting the generality
of the foregoing, the Investor has not relied on any statements or other information provided by or on behalf of the Placement Agents
or any of their respective affiliates or any control persons, officers, directors, employees, partners, agents or representatives of
any of the foregoing concerning Issuer, the Company, the Transaction, the Business Combination Agreement, this Subscription Agreement
or the transactions contemplated hereby or thereby, the Shares or the offer and sale of the Shares.

 

k.            The
Investor acknowledges and agrees that no federal or state agency has passed upon or endorsed the merits of the offering of the Shares
or made any findings or determination as to the fairness of this investment.

 

l.            The
Investor has full power, right and legal capacity to execute and deliver this Subscription Agreement and to perform its, his or her obligations
hereunder.

 

m.            This
Subscription Agreement has been duly authorized, executed and delivered by the Investor. This Subscription Agreement is enforceable against
the Investor in accordance with its terms, except as may be limited or otherwise affected by (i) bankruptcy, insolvency, fraudulent
conveyance, reorganization, moratorium or other laws relating to or affecting the rights of creditors generally, and (ii) principles
of equity, whether considered at law or equity.

 

n.            The
Investor is not (i) a person named on the List of Specially Designated Nationals and Blocked Persons, the Executive Order 13599
List, the Foreign Sanctions Evaders List, or the Sectoral Sanctions Identification List, each of which is administered by the U.S. Treasury
Department’s Office of Foreign Assets Control (“OFAC”) (collectively, “OFAC Lists”), (ii) acting
on behalf of one or more persons that are named on the OFAC Lists; (iii) located, resident or born in, or a citizen or national
of, Cuba, Iran, North Korea, Syria, the Crimea region of Ukraine or any other country or territory embargoed or subject to substantial
trade restrictions by the United States or (iv) a Designated National as defined in the Cuban Assets Control Regulations, 31 C.F.R.
Part 515 (each, a “Prohibited Investor”). The Investor agrees to provide law enforcement agencies, if requested
thereby, such records as required by applicable law, provided that the Investor is permitted to do so under applicable law. The Investor
also represents that, to the extent required, it, he or she maintains procedures reasonably designed to ensure compliance with OFAC-administered
sanctions programs. The Investor further represents and warrants that, to the extent required by applicable law, the Investor maintains
procedures reasonably designed to ensure that the funds held by the Investor and used to purchase the Shares were legally derived and
were not obtained, directly or indirectly, from a Prohibited Investor.

 

o.            The
Investor acknowledges that neither the Placement Agents, nor any of their respective affiliates nor any control persons, officers, directors,
employees, partners, agents or representatives of any of the foregoing have made any independent investigation with respect to Issuer,
the Company or its subsidiaries or any of their respective businesses, or the Shares or the accuracy, completeness or adequacy of any
information supplied to the Investor by Issuer.

 

p.            In
connection with the issue and purchase of the Shares, the Placement Agents have not acted as the Investor’s financial advisor or
fiduciary.

 

q.            The
Investor acknowledges that it, he or she is aware that Goldman Sachs & Co. LLC and J.P. Morgan Securities LLC are acting as
financial advisors to the Company in connection with the Transaction.

 

     

     

    

 

r.            The
Investor has and, when required to deliver payment to Issuer pursuant to Section 2 above, will have, sufficient funds to
pay the Subscription Amount and consummate the purchase and sale of the Shares pursuant to this Subscription Agreement.

 

s.            As
of the date hereof, the Investor does not have, and during the thirty (30) day period immediately prior to the date hereof the Investor
has not entered into, any “put equivalent position” as such term is defined in Rule 16a-1 under the Exchange Act or
short sale positions with respect to the securities of Issuer.

 

t.            The
Investor is not currently (and at all times through Closing will refrain from being or becoming) a member of a “group” (within
the meaning of Section 13(d)(3) or Section 14(d)(2) of the Exchange Act or any successor provision) acting for the
purpose of acquiring, holding, voting or disposing of equity securities of Issuer (within the meaning of Rule 13d-5(b)(1) under
the Exchange Act), other than a group consisting solely of the Investor and its, his or her affiliates.

 

7.            Registration
Rightsa.     .

 

a.            Issuer
agrees that within forty-five (45) calendar days after the Closing, it will file with the SEC (at its sole cost and expense) a registration
statement registering the resale of the Shares (the “Registration Statement”), and it shall use its commercially reasonable
efforts to have the Registration Statement declared effective as soon as practicable after the filing thereof, but no later than the
earlier of (i) ninety (90) calendar days after the filing thereof (or one hundred twenty (120) calendar days after the filing thereof
if the SEC notifies Issuer that it will “review” the Registration Statement) and (ii) ten (10) business days after
Issuer is notified (orally or in writing, whichever is earlier) by the SEC that the Registration Statement will not be “reviewed”
or will not be subject to further review. Issuer agrees to cause such Registration Statement, or another shelf registration statement
that includes the Shares to be sold pursuant to this Subscription Agreement, to remain effective until the earliest of (i) the second
anniversary of the Closing, (ii) the date on which the Investor ceases to hold any Shares issued pursuant to this Subscription Agreement,
or (iii) on the first date on which the Investor is able to sell all of its, his or her Shares issued pursuant to this Subscription
Agreement (or shares received in exchange therefor) under Rule 144 promulgated under the Securities Act (“Rule 144”)
within 90 days without the public information, volume or manner of sale limitations of such rule. The Investor agrees to disclose its,
his or her ownership to Issuer upon request to assist it, him or her in making the determination with respect to Rule 144 described
in clause (iii) above. In no event shall the Investor be identified as a statutory underwriter in the Registration Statement unless
in response to a comment or request from the staff of the SEC or another regulatory agency; provided, that if the SEC requests
that the Investor be identified as a statutory underwriter in the Registration Statement, the Investor will have an opportunity to withdraw
its, his or her Shares from the Registration Statement. Notwithstanding the foregoing, if the SEC prevents Issuer from including any
or all of the shares proposed to be registered under the Registration Statement due to limitations on the use of Rule 415 of the
Securities Act for the resale of the Shares by the applicable shareholders or otherwise, such Registration Statement shall register for
resale such number of Shares which is equal to the maximum number of Shares as is permitted by the SEC. In such event, the number of
Shares to be registered for each selling shareholder named in the Registration Statement shall be reduced pro rata among all such selling
shareholders. Issuer may amend the Registration Statement so as to convert the Registration Statement to a Registration Statement on
Form S-3 at such time after Issuer becomes eligible to use such Form S-3. The Investor acknowledges and agrees that the Issuer
may delay the filing or suspend the use of the Registration Statement if the Issuer determines that in order for such registration statement
not to contain a material misstatement or omission, an amendment thereto would be needed, or if such filing or use could materially affect
a bona fide business or financing transaction of Issuer, would require premature disclosure of information that would adversely affect
Issuer that would at that time not otherwise be required in a current, quarterly, or annual report under the Exchange Act or would require
the inclusion of financial statements that are unavailable to the Issuer for reasons beyond the Issuer’s control; provided,
that, (I) Issuer shall not so delay filing or so suspend the use of the Registration Statement for a period of more than ninety
(90) consecutive days or more than a total of one hundred-twenty (120) calendar days in any three hundred sixty (360) consecutive day
period and (II) Issuer shall use commercially reasonable efforts to make such Registration Statement available for the sale by the
Investor of such securities as soon as practicable thereafter. If so directed by Issuer, the Investor will destroy all copies of the
prospectus covering the Shares in the Investor’s possession; provided, however, that this obligation to destroy all copies of the
prospectus covering the Shares shall not apply (x) to the extent the Investor is required to retain a copy of such prospectus (A) in
order to comply with applicable legal or regulatory requirements or (B) in accordance with a bona fide pre-existing document retention
policy or (y) to copies stored electronically on archival servers as a result of automatic data back-up. Issuer’s obligations
to include the Shares issued pursuant to this Subscription Agreement (or shares issued in exchange therefor) for resale in the Registration
Statement are contingent upon the Investor furnishing in writing to Issuer such information regarding the Investor, the securities of
Issuer held by the Investor and the intended method of disposition of such Shares, which shall be limited to non-underwritten public
offerings, as shall be reasonably requested by Issuer to effect the registration of such Shares, and shall execute such documents in
connection with such registration as Issuer may reasonably request that are customary of a selling shareholder in similar situations.

 

     

     

    

 

b.            Indemnification

 

(i)            Issuer
shall, notwithstanding any termination of this Subscription Agreement, indemnify, defend and hold harmless Investor (to the extent a
seller under the Registration Statement), its officers, directors, agents, partners, members, managers, stockholders, affiliates (within
the meaning of Rule 405 under the Securities Act), employees and investment advisers, each person who controls Investor (within
the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act) and the officers, directors, partners, members,
managers, stockholders, agents, affiliates, employees and investment advisers of each such controlling person, to the fullest extent
permitted by applicable law, from and against any and all claims, suits, actions, or litigation brought by a third party that arise out
of or are based upon any untrue or alleged untrue statement of a material fact contained (or incorporated by reference) in the Registration
Statement, or arising out of or relating to any omission or alleged omission to state a material fact required to be stated therein or
necessary to make the statements therein (in the case of any prospectus or form of prospectus or supplement thereto, in light of the
circumstances under which they were made) not misleading, except to the extent, but only to the extent, that such untrue statements,
alleged untrue statements, omissions or alleged omissions are based solely upon information regarding Investor furnished in writing to
Issuer by or on behalf of Investor expressly for use therein (“Claim”), and any losses, damages, liabilities, costs (including,
without limitation, reasonable attorneys’ fees) and expenses (collectively, “Losses”) as incurred as a result of such
Claim. Issuer shall notify Investor of the institution, threat or assertion of any proceeding arising from or in connection with the
transactions contemplated by this Section 7 of which Issuer is aware. Notwithstanding the forgoing, Issuer’s indemnification
obligations shall not apply to amounts paid in settlement of any Losses or action if such settlement is effected without the prior written
consent of the Issuer (which consent shall not be unreasonably withheld or delayed).

 

(ii)            Investor
shall, severally and not jointly with any Other Investor or other selling securityholder named in the Registration Statement, indemnify
and hold harmless Issuer, its directors, officers, agents and employees, each person who controls the Issuer (within the meaning of Section 15
of the Securities Act and Section 20 of the Exchange Act), and the directors, officers, agents or employees of such controlling
persons, to the fullest extent permitted by applicable law, from and against all Losses, as incurred, arising out of or are based upon
any untrue or alleged untrue statement of a material fact contained in any Registration Statement, or arising out of or relating to any
omission or alleged omission of a material fact required to be stated therein or necessary to make the statements therein (in the case
of any prospectus, or any form of prospectus or supplement thereto, in light of the circumstances under which they were made) not misleading
to the extent, but only to the extent, that such untrue statements or omissions are based solely upon information regarding Investor
furnished in writing to Issuer by or on behalf of Investor expressly for use therein. In no event shall the liability of Investor be
greater in amount than the dollar amount of the net proceeds received by Investor upon the sale of the Shares giving rise to such indemnification
obligation. Notwithstanding the forgoing, Investor’s indemnification obligations shall not apply to amounts paid in settlement
of any Losses or action if such settlement is effected without the prior written consent of Investor (which consent shall not be unreasonably
withheld or delayed).

 

(iii)            Any
person entitled to indemnification herein shall (i) give prompt written notice to the indemnifying party of any claim with respect
to which it seeks indemnification (provided that the failure to give prompt notice shall not impair any person’s right to indemnification
hereunder to the extent such failure has not prejudiced the indemnifying party) and (ii) permit such indemnifying party to assume
the defense of such claim with counsel reasonably satisfactory to the indemnified party. If such defense is assumed, the indemnifying
party shall not be subject to any liability for any settlement made by the indemnified party without its consent. An indemnifying party
who elects not to assume the defense of a claim shall not be obligated to pay the fees and expenses of more than one counsel for all
parties indemnified by such indemnifying party with respect to such claim, unless in the reasonable judgment of legal counsel to any
indemnified party a conflict of interest exists between such indemnified party and any other of such indemnified parties with respect
to such claim. No indemnifying party shall, without the consent of the indemnified party, consent to the entry of any judgment or enter
into any settlement which cannot be settled in all respects by the payment of money (and such money is so paid by the indemnifying party
pursuant to the terms of such settlement) or which settlement does not include as an unconditional term thereof the giving by the claimant
or plaintiff to such indemnified party of a release from all liability in respect to such claim or litigation.

 

     

     

    

 

(iv)            The
indemnification provided for under this Subscription Agreement shall remain in full force and effect regardless of any investigation
made by or on behalf of the indemnified party or any officer, director, employee, agent, affiliate or controlling person of such indemnified
party and shall survive the transfer of the Shares purchased pursuant to this Subscription Agreement.

 

(v)            If
the indemnification provided under this Section 7(b) from the indemnifying party is unavailable or insufficient to hold harmless
an indemnified party in respect of any losses, claims, damages, liabilities and expenses referred to herein, then the indemnifying party,
in lieu of indemnifying the indemnified party, shall contribute to the amount paid or payable by the indemnified party as a result of
such losses, claims, damages, liabilities and expenses in such proportion as is appropriate to reflect the relative fault of the indemnifying
party and the indemnified party, as well as any other relevant equitable considerations; provided that in no event shall the liability
of Investor be greater in amount than the dollar amount of the net proceeds received by Investor upon the sale of the Shares giving rise
to such contribution obligation. The relative fault of the indemnifying party and indemnified party shall be determined by reference
to, among other things, whether any action in question, including any untrue or alleged untrue statement of a material fact or omission
or alleged omission to state a material fact, was made by, or relates to information supplied by, such indemnifying party or indemnified
party, and the indemnifying party’s and indemnified party’s relative intent, knowledge, access to information and opportunity
to correct or prevent such action. The amount paid or payable by a party as a result of the losses or other liabilities referred to above
shall be subject to the limitations set forth in this Section 7 and deemed to include any legal or other fees, charges or expenses
reasonably incurred by such party in connection with any investigation or proceeding. No person guilty of fraudulent misrepresentation
(within the meaning of Section 11(f) of the Securities Act) shall be entitled to contribution pursuant to this Section 7(b) from
any person who was not guilty of such fraudulent misrepresentation. Each indemnifying party’s obligation to make a contribution
pursuant to this Section 7(b)(v) shall be individual, not joint and several, and in no event shall the liability of Investor
hereunder exceed the net proceeds received by Investor upon the sale of the Shares giving rise to such indemnification obligation. Notwithstanding
anything to the contrary herein, in no event will any party be liable for consequential, special, exemplary or punitive damages in connection
with this Subscription Agreement.

 

8.            Termination.
This Subscription Agreement shall terminate and be void and of no further force and effect, and all rights and obligations of the
parties hereunder shall terminate without any further liability on the part of any party in respect thereof, upon the earliest to occur
of (a) such date and time as the Business Combination Agreement is terminated in accordance with its terms without being
consummated, (b) upon the mutual written agreement of each of the parties hereto and the Company to terminate this Subscription
Agreement, or (c) 30 days after the Outside Date (as defined in the Business Combination Agreement as in effect on the date hereof),
if the Closing has not occurred by such date (provided, that the right to terminate this Subscription Agreement pursuant to this clause
(c) shall not be available to the Investor if the Investor’s breach of any of its, his or her covenants or obligations under
this Subscription Agreement (or if an affiliate of the Investor is one of the Other Investors under an Other Subscription Agreement,
and such Other Investor’s breach of any of its, his or her covenants or obligations under the Other Subscription Agreement), either
individually or in the aggregate, shall have proximately caused the failure of the consummation of the Transaction on or before the Outside
Date) (the termination events described in clauses (a)–(c) above, collectively, the “Termination Events”);
provided that nothing herein will relieve any party from liability for any willful breach hereof prior to the time of termination, and
each party will be entitled to any remedies at law or in equity to recover losses, liabilities or damages arising from any such willful
breach. Issuer shall notify the Investor in writing of the termination of the Business Combination Agreement promptly after the termination
of such agreement. Upon the occurrence of any Termination Event, this Subscription Agreement shall be void and of no further effect and
any monies paid by the Investor to Issuer in connection herewith shall promptly (and in any event within one (1) business day) following
the Termination Event be returned to the Investor.

 

     

     

    

 

9.            Trust
Account Waiver. The Investor acknowledges that Issuer is a blank check company with the powers and privileges to effect a merger,
asset acquisition, reorganization or similar business combination involving Issuer and one or more businesses or assets. The Investor
further acknowledges that, as described in Issuer’s prospectus relating to its initial public offering dated July 30, 2020
(the “Prospectus”) available at www.sec.gov, substantially all of Issuer’s assets consist of the cash proceeds
of Issuer’s initial public offering and private placement of its securities, and substantially all of those proceeds have been
deposited in a trust account (the “Trust Account”) for the benefit of Issuer, its public shareholders and the underwriters
of Issuer’s initial public offering. Except with respect to interest earned on the funds held in the Trust Account that may be
released to Issuer to pay its tax obligations and to fund certain of its working capital requirements, the cash in the Trust Account
may be disbursed only for the purposes set forth in the Prospectus. For and in consideration of Issuer entering into this Subscription
Agreement, the receipt and sufficiency of which are hereby acknowledged, the Investor, on behalf of itself, himself or herself and its,
his or her representatives hereby irrevocably waives any and all right, title and interest, or any claim of any kind it, he or she has
or may have in the future, in or to any monies held in the Trust Account (or distributions therefrom to Issuer’s public shareholders
or to the underwriters of Issuer’s initial public offering in respect of their deferred underwriting commissions held in the Trust
Account), and agrees not to seek recourse against the Trust Account; provided, however, that nothing in this Section 9
shall be deemed to limit the Investor’s right, title, interest or claim to any monies held in the Trust Account by virtue of
its record or beneficial ownership of Shares currently outstanding on the date hereof, pursuant to a validly exercised redemption right
with respect to any such Shares, except to the extent that the Investor has otherwise agreed with Issuer to not exercise such redemption
right.

 

10.            Miscellaneous.

 

a.            Neither
this Subscription Agreement nor any rights that may accrue to the parties hereunder (other than the Shares acquired hereunder, if any)
may be transferred or assigned without the prior written consent of each of the other parties hereto; provided that (i) this Subscription
Agreement and any of the Investor’s rights and obligations hereunder may be assigned to any fund or account managed by the same
investment manager as the Investor or by an affiliate (as defined in Rule 12b-2 of the Exchange Act) of such investment manager
without the prior consent of Issuer and (ii) the Investor's rights under Section 7 may be assigned to an assignee or
transferee of the Shares (other than in connection with a sale of the Shares); provided further that prior to such assignment any such
assignee shall agree in writing to be bound by the terms hereof; provided, that no assignment pursuant to clause (i) of this Section 10(a) shall
relieve the Investor of its, his or her obligations hereunder unless otherwise agreed to in writing by Issuer.

 

b.            Issuer
may request from the Investor such additional information as Issuer may deem necessary to register the resale of the Shares and evaluate
the eligibility of the Investor to acquire the Shares, and the Investor shall promptly provide such information as may reasonably be
requested to the extent readily available. The Investor acknowledges and agrees that if it, he or she does not provide Issuer with such
requested information, Issuer may not be able to register the Investor's Shares for resale pursuant to Section 7 hereof.
The Investor acknowledges that Issuer may file a copy of this Subscription Agreement (or a form of this Subscription Agreement) with
the SEC as an exhibit to a periodic report or a registration statement of Issuer.

 

c.            The
Investor acknowledges that Issuer, the Company, the Placement Agents, and others will rely on the acknowledgments, understandings, agreements,
representations and warranties contained in this Subscription Agreement, including Schedule A hereto. Prior to the Closing, the Investor
agrees to promptly notify Issuer, the Company and the Placement Agents in writing (including, for the avoidance of doubt, by email) if
any of the acknowledgments, understandings, agreements, representations and warranties made by the Investor as set forth in Section 6
above are no longer accurate in any material respect (other than those acknowledgments, understandings, agreements, representations
and warranties qualified by materiality, in which case the Investor shall notify Issuer and the Placement Agents if they are no longer
accurate in any respect). The Investor acknowledges and agrees that each purchase by the Investor of Shares from Issuer will constitute
a reaffirmation of the acknowledgments, understandings, agreements, representations and warranties herein (as modified by any such notice)
by the Investor as of the time of such purchase.

 

d.            Issuer,
the Company and the Placement Agents are each entitled to rely upon this Subscription Agreement and each is irrevocably authorized to
produce this Subscription Agreement or a copy hereof to any interested party in any administrative or legal proceeding or official inquiry
with respect to the matters covered hereby; provided, however, that the foregoing clause of this Section 10(d) shall
not give the Company or the Placement Agents any rights other than those expressly set forth herein and, without limiting the generality
of the foregoing and for the avoidance of doubt, in no event shall the Company be entitled to rely on any of the representations and
warranties of Issuer set forth in this Subscription Agreement.

 

     

     

    

 

e.            This
Subscription Agreement may not be amended, modified, waived or terminated (other than pursuant to the terms of Section 8
above) except by an instrument in writing, signed by each of the parties hereto, provided, however, that no modification
or waiver by Issuer of the provisions of this Subscription Agreement shall be effective without the prior written consent of the Company
(other than modifications, amendments or waivers that are solely ministerial in nature or otherwise immaterial and do not affect any
economic or any other material term of this Subscription Agreement). No failure or delay of any party in exercising any right or remedy
hereunder shall operate as a waiver thereof, nor shall any single or partial exercise of any such right or power, or any abandonment
or discontinuance of steps to enforce such right or power, or any course of conduct, preclude any other or further exercise thereof or
the exercise of any other right or power. The rights and remedies of the parties hereunder are cumulative and are not exclusive of any
rights or remedies that they would otherwise have hereunder.

 

f.            This
Subscription Agreement (including the schedule hereto) constitutes the entire agreement, and supersedes all other prior agreements, understandings,
representations and warranties, both written and oral, among the parties hereto, with respect to the subject matter hereof. Except as
set forth in Section 8, Section 10(c), Section 10(d), Section 10(e), this Section 10(f),
Section 10(k) and Section 11 with respect to the persons specifically referenced therein, and Section 6
and Section 11 with respect to the Placement Agents, this Subscription Agreement shall not confer any rights or remedies
upon any person other than the parties hereto, and their respective successors and assigns, and the parties hereto acknowledge that such
persons so referenced are third party beneficiaries of this Subscription Agreement with right of enforcement for the purposes of, and
to the extent of, the rights granted to them, if any, pursuant to the applicable provisions; provided, that, notwithstanding anything
to the contrary contained in this Subscription Agreement, the Company is an intended third party beneficiary of each of the provisions
of this Subscription Agreement.

 

g.            Except
as otherwise provided herein, this Subscription Agreement shall be binding upon, and inure to the benefit of the parties hereto and their
heirs, executors, administrators, successors, legal representatives, and permitted assigns, and the agreements, representations, warranties,
covenants and acknowledgments contained herein shall be deemed to be made by, and be binding upon, such heirs, executors, administrators,
successors, legal representatives and permitted assigns.

 

h.            If
any provision of this Subscription Agreement shall be adjudicated by a court of competent jurisdiction to be invalid, illegal or unenforceable,
the validity, legality or enforceability of the remaining provisions of this Subscription Agreement shall not in any way be affected
or impaired thereby and shall continue in full force and effect.

 

i.            This
Subscription Agreement may be executed and delivered in one (1) or more counterparts (including by electronic means, such as facsimile,
in .pdf or any electronic signature complying with the U.S. federal ESIGN Act of 2000) and by different parties in separate counterparts,
with the same effect as if all parties hereto had signed the same document. All counterparts so executed and delivered shall be construed
together and shall constitute one and the same agreement.

 

j.            At
any time, Issuer may (a) extend the time for the performance of any obligation or other act of the Investor, (b) waive
any inaccuracy in the representations and warranties of the Investor contained herein or in any document delivered by the Investor pursuant
hereto and (c) waive compliance with any agreement of the Investor or any condition to its own obligations contained herein. At
any time, the Investor may (a) extend the time for the performance of any obligation or other act of Issuer, (b) waive any
inaccuracy in the representations and warranties of Issuer contained herein or in any document delivered by Issuer pursuant hereto and
(c) waive compliance with any agreement of Issuer or any condition to its, his or her own obligations contained herein. Any such
extension or waiver shall only be valid if set forth in an instrument in writing signed by the party or parties to be bound thereby.

 

k.            The
parties hereto acknowledge and agree that irreparable damage would occur in the event that any of the provisions of this Subscription
Agreement were not performed in accordance with their specific terms or were otherwise breached. It is accordingly agreed that the parties
hereto shall be entitled to an injunction or injunctions to prevent breaches of this Subscription Agreement, without posting a bond or
undertaking and without proof of damages, to enforce specifically the terms and provisions of this Subscription Agreement, this being
in addition to any other remedy to which such party is entitled at law, in equity, in contract, in tort or otherwise. The parties hereto
acknowledge and agree that the Company shall be entitled to specifically enforce the Investor’s obligations to fund the Subscription
Amount and the provisions of this Subscription Agreement, in each case, on the terms and subject to the conditions set forth herein.

 

     

     

    

 

l.            This
Subscription Agreement shall be governed by and construed in accordance with the laws of the State of Delaware (regardless of the laws
that might otherwise govern under applicable principles of conflicts of laws thereof) as to all matters (including any action, suit,
litigation, arbitration, mediation, claim, charge, complaint, inquiry, proceeding, hearing, audit, investigation or reviews by or before
any governmental entity related hereto), including matters of validity, construction, effect, performance and remedies.

 

m.            Each
party hereto hereby, and any person asserting rights as a third party beneficiary may do so only if he, she or it, irrevocably agrees
that any action, suit or proceeding between or among the parties hereto, whether arising in contract, tort or otherwise, arising in connection
with any disagreement, dispute, controversy or claim arising out of or relating to this Subscription Agreement or any related document
or any of the transactions contemplated hereby or thereby (“Legal Dispute”) shall be brought only to the exclusive
jurisdiction of the courts of the State of Delaware or the federal courts located in the State of Delaware, and each party hereto hereby
consents to the jurisdiction of such courts (and of the appropriate appellate courts therefrom) in any such suit, action or proceeding
and irrevocably waives, to the fullest extent permitted by law, any objection that it, he or she may now or hereafter have to the laying
of the venue of any such suit, action or proceeding in any such court or that any such suit, action or proceeding that is brought in
any such court has been brought in an inconvenient forum. During the period a Legal Dispute that is filed in accordance with this Section 10(m) is
pending before a court, all actions, suits or proceedings with respect to such Legal Dispute or any other Legal Dispute, including any
counterclaim, cross-claim or interpleader, shall be subject to the exclusive jurisdiction of such court. Each party hereto and any person
asserting rights as a third party beneficiary may do so only if he, she or it hereby waives, and shall not assert as a defense in any
Legal Dispute, that (a) such party is not personally subject to the jurisdiction of the above named courts for any reason, (b) such
action, suit or proceeding may not be brought or is not maintainable in such court, (c) such party’s property is exempt or
immune from execution, (d) such action, suit or proceeding is brought in an inconvenient forum, or (e) the venue of such action,
suit or proceeding is improper. A final judgment in any action, suit or proceeding described in this Section 10(m) following
the expiration of any period permitted for appeal and subject to any stay during appeal shall be conclusive and may be enforced in other
jurisdictions by suit on the judgment or in any other manner provided by applicable laws. EACH OF THE PARTIES HERETO AND ANY PERSON ASSERTING
RIGHTS AS A THIRD PARTY BENEFICIARY MAY DO SO ONLY IF HE, SHE OR IT IRREVOCABLY AND UNCONDITIONALLY WAIVES ANY RIGHT TO TRIAL BY
JURY ON ANY CLAIMS OR COUNTERCLAIMS ASSERTED IN ANY LEGAL DISPUTE RELATING TO THIS SUBSCRIPTION AGREEMENT OR THE TRANSACTIONS CONTEMPLATED
HEREBY AND FOR ANY COUNTERCLAIM RELATING THERETO. IF THE SUBJECT MATTER OF ANY SUCH LEGAL DISPUTE IS ONE IN WHICH THE WAIVER OF JURY
TRIAL IS PROHIBITED, NO PARTY HERETO NOR ANY PERSON ASSERTING RIGHTS AS A THIRD PARTY BENEFICIARY SHALL ASSERT IN SUCH LEGAL DISPUTE
A NONCOMPULSORY COUNTERCLAIM ARISING OUT OF OR RELATING TO THIS SUBSCRIPTION AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY. FURTHERMORE,
NO PARTY HERETO NOR ANY PERSON ASSERTING RIGHTS AS A THIRD PARTY BENEFICIARY SHALL SEEK TO CONSOLIDATE ANY SUCH LEGAL DISPUTE WITH A
SEPARATE ACTION OR OTHER LEGAL PROCEEDING IN WHICH A JURY TRIAL CANNOT BE WAIVED.

 

n.            Any
notice or communication required or permitted hereunder to be given to the Investor shall be in writing and either delivered personally,
emailed, sent by overnight mail via a reputable overnight carrier, or sent by certified or registered mail, postage prepaid, to such
address(es) or email address(es) set forth on the signature page hereto, and shall be deemed to be given and received (i) when
so delivered personally, (ii) when sent, with no mail undeliverable or other rejection notice, if sent by email, or (iii) three
(3) business days after the date of mailing to the address below or to such other address or addresses as such person may hereafter
designate by notice given hereunder:

 

     

     

    

 

(i)            if
to the Investor, to such address or addresses set forth on the signature page hereto;

 

(ii)            if
to Issuer, to:

 

CC Neuberger Principal Holdings II 

200 Park Avenue, 

58th Floor 

New York, New York 10166 

Attn:
Matthew Skurbe

 

with a required copy to (which copy shall not constitute notice):

 

Kirkland & Ellis LLP 

601 Lexington Avenue 

New York, New York 10022 

Attn:
Peter Seligson

 

o.            If
Investor is a Massachusetts Business Trust, a copy of the Declaration of Trust of Investor or any affiliate thereof is on file with the
Secretary of State of the Commonwealth of Massachusetts and notice is hereby given that the Subscription Agreement is executed on behalf
of the trustees of Investor or any affiliate thereof as trustees and not individually and that the obligations of the Subscription Agreement
are not binding on any of the trustees or stockholders of Investor or any affiliate thereof individually but are binding only upon Investor
or any affiliate thereof and its, his or her assets and property.

 

p.            The
Issuer shall use commercially reasonable efforts, if requested by Subscriber to, within five (5) business days of such request,
(i) issue to the transfer agent a legal opinion instructing the transfer agent that, in connection with a sale or transfer of “restricted
securities” (i.e., securities issued pursuant to an exemption from the registration requirements of Section 5 of the
Securities Act), the resale or transfer of which restricted securities has been registered pursuant to an effective Registration Statement
by the holder thereof named in such Registration Statement, upon receipt of an appropriate broker representation letter and other such
documentation as the Issuer's counsel deems necessary and appropriate and after confirming compliance with relevant prospectus delivery
requirements, is authorized to remove any applicable restrictive legend in connection with such sale or transfer and (ii) if the
Shares are not registered pursuant to an effective Registration Statement, issue to the transfer agent a legal opinion to facilitate
the sale or transfer of the Shares and removal of any restrictive legends pursuant to any exemption from the registration requirements
of Section 5 of the Securities Act that may be available to a requesting Investor; provided that, (A) the Issuer and
its counsel may request and rely upon customary representations from the Investor in connection with delivery of such opinion and (B) notwithstanding
the foregoing, the Issuer and its counsel will not be required to deliver any such opinion, authorization, certificate or direction if
it reasonably believes that removal of the legend could result in or facilitate transfers of securities in violation of applicable law.

 

     

     

    

 

11.            Non-Reliance
and Exculpation. The Investor acknowledges that it, he or she is not relying upon, and has not relied upon, any statement, representation
or warranty made by any person, firm or corporation (including, without limitation, the Placement Agents, any of their respective affiliates
or any control persons, officers, directors, employees, partners, agents or representatives of any of the foregoing), other than the
statements, representations and warranties of Issuer expressly contained in Section 5 of this Subscription Agreement, in
making its, his or her investment or decision to invest in Issuer. The Investor acknowledges and agrees that none of (i) any Other
Investor pursuant to any Other Subscription Agreement (including such Other Investor’s respective affiliates or any control persons,
officers, directors, employees, partners, agents or representatives of any of the foregoing), (ii) the Placement Agents, their respective
affiliates or any control persons, officers, directors, employees, partners, agents or representatives of any of the foregoing, or (iii) any
other party to the Business Combination Agreement or any Non-Party Affiliate, shall have any liability to the Investor, or to any Other
Investor, pursuant to, arising out of or relating to this Subscription Agreement or any other subscription agreement related to the private
placement of the Shares, the negotiation hereof or thereof or its subject matter, or the transactions contemplated hereby or thereby,
including, without limitation, with respect to any action heretofore or hereafter taken or omitted to be taken by any of them in connection
with the purchase of the Shares or with respect to any claim (whether in tort, contract, under federal or state securities laws or otherwise)
for breach of this Subscription Agreement or in respect of any written or oral representations made or alleged to be made in connection
herewith, as expressly provided herein, or for any actual or alleged inaccuracies, misstatements or omissions with respect to any information
or materials of any kind furnished by Issuer, the Company, the Placement Agents or any Non-Party Affiliate concerning Issuer, the Company,
the Placement Agents, any of their controlled affiliates, this Subscription Agreement or the transactions contemplated hereby. For purposes
of this Subscription Agreement, “Non-Party Affiliates” means each former, current or future officer, director, employee,
partner, member, manager, direct or indirect equityholder or affiliate of Issuer, the Company, the Placement Agents or any of Issuer’s,
the Company’s or the Placement Agents’ controlled affiliates or any family member of the foregoing.

 

12.            No
Hedging. The Investor agrees that, from the date hereof until the Closing or the earlier termination of this Subscription Agreement,
none of the Investor or any person or entity acting on behalf of the Investor or pursuant to any understanding with the Investor will
engage in any hedging or other transactions or arrangements (including, without limitation, any short sale or the purchase or sale of,
or entry into, any put or call option, or combination thereof, forward, swap or any other derivative transaction or similar instrument,
including without limitation equity repurchase agreements and securities lending arrangements, however described or defined) designed
or intended, or which could reasonably be expected to lead to or result in, a sale, loan, pledge or other disposition or transfer (whether
by the Investor or any other person), in each case, solely to the extent it has the same economic effect as a “short sale”
(as defined in Rule 200 promulgated under Regulation SHO under the Exchange Act), of any economic consequences of ownership (excluding,
for the avoidance of doubt, any consequences resulting solely from foreign exchange fluctuations), in whole or in part, directly or indirectly,
physically or synthetically, of any Shares or any securities of Issuer prior to the Closing, whether any such transaction or arrangement
(or instrument provided for thereunder) would be settled by delivery of securities of Issuer, in cash or otherwise, or to publicly disclose
the intention to undertake any of the foregoing; provided, however, that the provisions of this Section 12 shall not apply
to long sales (including sales of securities held by the Investor, its, his or her controlled affiliates or any person or entity acting
on behalf of the Investor or any of its, his or her controlled affiliates prior to the date hereof and securities purchased by the Investor
in the open market after the date hereof) other than those effectuated through derivative transactions and similar instruments.

 

[SIGNATURE PAGES FOLLOW]

 

     

     

    

 

IN
WITNESS WHEREOF, the Investor has executed or caused this Subscription Agreement to be executed by its, his or her duly authorized
representative as of the date set forth below.

 

	Name of Investor:	State/Country of Formation or Domicile:
    
	 	 
	By:  	            	 	 
	Name:  	 	 	 
	Title:  	 	 	 
	 	 
	Name in which Shares are to be registered (if different):	Date: ________, 2021
	 	 
	Investor’s EIN:	 
	 	 
	Business Address-Street:	Mailing Address-Street (if different):
	 	 
	City, State, Zip:	City, State, Zip:
	 	 
	Attn:  	 	 	Attn:  	        
	 	 
	Telephone No.:	Telephone No.:
	 	 
	Facsimile No.:

    
	Facsimile No.:
	 	 
	Email:	 
	 	 
	Number of Shares subscribed for: 	 
	 	 
	Aggregate Subscription Amount: $ 	Price Per Share: $10.00
	 	 

 

You must pay the Subscription
Amount by wire transfer of United States dollars in immediately available funds to the account specified by Issuer in the Closing Notice.
To the extent the offering is oversubscribed the number of Shares received and the Subscription Amount may be less than the maximum number
of Shares subscribed for.

 

[Signature Page to Subscription Agreement]

 

     

     

    

 

IN WITNESS WHEREOF, SPAC
and New CCNB have each accepted this Subscription Agreement as of the date set forth below.

 

	 	CC NEUBERGER PRINCIPAL HOLDINGS II
	 	 
	 	 
	 	By:  	         
	 	Name:  
	 	Title:    
	 	 	 
	 	 	 
	 	VECTOR HOLDING, LLC
	 	 
	 	 
	 	By: 	 
	 	Name:
	 	Title

 

Date:                ,
2021

 

[Signature Page to
Subscription Agreement]

 

     

     

    

  

SCHEDULE A

 

ELIGIBILITY REPRESENTATIONS
OF THE INVESTOR

 

This
Schedule must be completed by Investor and forms a part of the Subscription Agreement to which it is attached. Capitalized terms used
and not otherwise defined in this Schedule have the meanings given to them in the Subscription Agreement. The Investor must check
the applicable box below.

 

	 	ACCREDITED INVESTOR STATUS

 

	 	(Please check the applicable subparagraphs):

 

	 	1.	 ̈  We are an “accredited
    investor” (within the meaning of Rule 501(a) under the Securities Act or an entity in which all of the equity holders
    are accredited investors within the meaning of Rule 501(a) under the Securities Act), and have marked and initialed the
    appropriate box below indicating the provision under which we qualify as an “accredited investor.”

 

	 	2.     ̈  We
    are not a natural person.

 

Rule 501(a) under the Securities
Act, in relevant part, states that an “accredited investor” shall mean any person who comes within any of the below listed
categories, or who the issuer reasonably believes comes within any of the below listed categories, at the time of the sale of the securities
to that person. The Investor has indicated, by marking and initialing the appropriate box below, the provision(s) below which apply
to the Investor and under which the Investor accordingly qualifies as an “accredited investor.”

 

 ̈  Any
bank, registered broker or dealer, insurance company, registered investment company, business development company, or small business
investment company;

 

 ̈  Any
plan established and maintained by a state, its political subdivisions, or any agency or instrumentality of a state or its political
subdivisions for the benefit of its employees, if such plan has total assets in excess of $5,000,000;

 

 ̈  Any
employee benefit plan, within the meaning of the Employee Retirement Income Security Act of 1974, if a bank, insurance company, or registered
investment adviser makes the investment decisions, or if the plan has total assets in excess of $5,000,000;

 

 ̈  Any
organization described in Section 501(c)(3) of the Internal Revenue Code, corporation, similar business trust, or partnership,
not formed for the specific purpose of acquiring the securities offered, with total assets in excess of $5,000,000;

 

 ̈  Any
director, executive officer, or general partner of the issuer of the securities being offered or sold, or any director, executive officer,
or general partner of a general partner of that issuer;

 

 ̈  Any
natural person whose individual net worth, or joint net worth with that person’s spouse, exceeds $1,000,000. For purposes of calculating
a natural person’s net worth: (a) the person’s primary residence shall not be included as an asset; (b) indebtedness
that is secured by the person’s primary residence, up to the estimated fair market value of the primary residence at the time of
the sale of securities, shall not be included as a liability (except that if the amount of such indebtedness outstanding at the time
of sale of securities exceeds the amount outstanding sixty (60) days before such time, other than as a result of the acquisition of the
primary residence, the amount of such excess shall be included as a liability); and (c) indebtedness that is secured by the person’s
primary residence in excess of the estimated fair market value of the primary residence at the time of the sale of securities shall be
included as a liability;

 

 ̈  Any
natural person who had an individual income in excess of $200,000 in each of the two most recent years or joint income with that person’s
spouse in excess of $300,000 in each of those years and has a reasonable expectation of reaching the same income level in the current
year;

 

     

     

    

 

 ̈  Any
natural person holding in good standing one or more professional certifications or designations or credentials from an accredited educational
institution that the SEC has designated as qualifying an individual for accredited investor status, such as a General Securities Representative
license (Series 7), a Private Securities Offerings Representative license (Series 82) and an Investment Adviser Representative
license (Series 65);

 

 ̈  Any
trust with assets in excess of $5,000,000, not formed to acquire the securities offered, whose purchase is directed by a sophisticated
person; or

 

 ̈  Any
entity in which all of the equity owners are accredited investors meeting one or more of the above tests.

 

This page should
be completed by the Investor 

and constitutes
a part of the Subscription Agreement.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00338-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00338-of-00352.parquet"}]]